OBJECTIVE: To find what the mortality rate of space-occupying ('malignant') middle cerebral artery (MCA) infarction is under maximum conservative intensive care. To establish whether any early indicators of survival exist. DESIGN: Prospective descriptive study. SETTING: Neuro-critical care unit of a university hospital. PATIENTS: Fifty-three patients (mean age 64 +/- 10 years) with 'malignant' MCA infarction. INTERVENTIONS: Maximum conservative intensive care using a standardized protocol (heparin, osmotherapy, tromethamol, mild hyperventilation). The start of therapy was within 12 h after the onset of symptoms. MEASUREMENTS AND RESULTS: The Glasgow Coma Scale (GCS) and Scandinavian Stroke Scale (SSS) were recorded daily. A computed tomography (CT) scan was performed on admission, on day 3 and on day 7. SSS, Barthel Index and Rankin Scale of the surviving patients were recorded after 3 months. On admission, the mean GCS was 13 +/- 3 points and mean SSS 18 +/- 7 points. All patients had to undergo mechanical ventilation (23 +/- 26 h after the onset of symptoms) and were comatose after 28 +/- 30 h. Of 53 patients, 37 (70%) suffered brain death in the intensive care unit (ICU) after an average of 90 +/- 59 h. After 3 months 42/53 (79 %) patients had died. The Barthel Index of the surviving patients was 54 +/- 12 points, the SSS 25 +/- 9 points and the Rankin Scale 3 +/- 1 points. The deceased patients had a significantly higher body temperature on admission than the surviving patients (36.8 degrees C vs 36.3 degrees C). CONCLUSIONS: The mortality of patients with 'malignant' MCA infarction is very high despite maximum conservative intensive care.
OBJECTIVE: To find what the mortality rate of space-occupying ('malignant') middle cerebral artery (MCA) infarction is under maximum conservative intensive care. To establish whether any early indicators of survival exist. DESIGN: Prospective descriptive study. SETTING: Neuro-critical care unit of a university hospital. PATIENTS: Fifty-three patients (mean age 64 +/- 10 years) with 'malignant' MCA infarction. INTERVENTIONS: Maximum conservative intensive care using a standardized protocol (heparin, osmotherapy, tromethamol, mild hyperventilation). The start of therapy was within 12 h after the onset of symptoms. MEASUREMENTS AND RESULTS: The Glasgow Coma Scale (GCS) and Scandinavian Stroke Scale (SSS) were recorded daily. A computed tomography (CT) scan was performed on admission, on day 3 and on day 7. SSS, Barthel Index and Rankin Scale of the surviving patients were recorded after 3 months. On admission, the mean GCS was 13 +/- 3 points and mean SSS 18 +/- 7 points. All patients had to undergo mechanical ventilation (23 +/- 26 h after the onset of symptoms) and were comatose after 28 +/- 30 h. Of 53 patients, 37 (70%) suffered brain death in the intensive care unit (ICU) after an average of 90 +/- 59 h. After 3 months 42/53 (79 %) patients had died. The Barthel Index of the surviving patients was 54 +/- 12 points, the SSS 25 +/- 9 points and the Rankin Scale 3 +/- 1 points. The deceased patients had a significantly higher body temperature on admission than the surviving patients (36.8 degrees C vs 36.3 degrees C). CONCLUSIONS: The mortality of patients with 'malignant' MCA infarction is very high despite maximum conservative intensive care.
Authors: D W Marion; L E Penrod; S F Kelsey; W D Obrist; P M Kochanek; A M Palmer; S R Wisniewski; S T DeKosky Journal: N Engl J Med Date: 1997-02-20 Impact factor: 91.245
Authors: Elton R Migliati; Mahmood Amiry-Moghaddam; Stanley C Froehner; Marvin E Adams; Ole Petter Ottersen; Anish Bhardwaj Journal: Neurocrit Care Date: 2010-08 Impact factor: 3.210
Authors: Arnold Cheung; Christopher K Telaghani; Jianli Wang; Qing Yang; Timothy J Mosher; Raymond K Reichwein; Kevin M Cockroft Journal: Neurocrit Care Date: 2005 Impact factor: 3.210
Authors: Hannah X Chu; Hyun Ah Kim; Seyoung Lee; Jeffrey P Moore; Christopher T Chan; Antony Vinh; Mathias Gelderblom; Thiruma V Arumugam; Brad R S Broughton; Grant R Drummond; Christopher G Sobey Journal: J Cereb Blood Flow Metab Date: 2013-12-11 Impact factor: 6.200